Future of bioelectronics takes center stage at Rice Global Paris event
The Rice Global Paris Center hosted the BioElectronic Therapeutics (BETx) conference and workshop June 27-28, the first formal event dedicated to the field of bioelectronics to be held at Rice’s Paris campus.
Rice lab develops smallest free-floating bubbles for medical imaging
Bioengineering researchers at Rice have developed ultrasmall, stable, gas-filled protein nanostructures that could revolutionize ultrasound imaging and drug delivery for cancers and infectious diseases.
Rice research aims to reprogram the genetic code
Chemist Han Xiao has been awarded nearly $2 million from the National Institutes of Health Maximizing Investigators’ Research Award.
Rice and MD Anderson launch Cancer Bioengineering Collaborative
Rice and the University of Texas MD Anderson Cancer Center today announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment.
New CPRIT chemistry professor to enhance cancer research at Rice
Rice’s Department of Chemistry will soon welcome Professor David Sarlah.
Rice and Houston Community College collaborate to diversify access to biomedical research training
Rice and Houston Community College collaborate to diversify access to biomedical research training through program funded by a $1.8M NIH grant.
Rice researchers stride to unlock mysteries of human development
A research team from Rice University led by Aryeh Warmflash has made strides in understanding the processes that guide human embryonic development. The group’s findings were published in the scientific journal Cells Systems May 15.
Rice study identifies protein responsible for gas vesicle clustering in bacteria
Rice University bioengineers and colleagues at Washington University in Saint Louis and Duke University identified a protein nanostructure that plays a role in the cellular structure of certain microorganisms, paving the way to more efficient biotechnological and biomedical applications.
Rice’s new Synthesis X Center has winning formula for cancer innovation
Rice has created the new Synthesis X Center to bring together clinicians treating cancer and researchers looking for cures to help spur drug discovery make precision adjustments to drug properties and translate fundamental research discoveries into clinical applications.
Rice’s Wiess School launches Center for Nanoscale Imaging Sciences
The Wiess School of Natural Sciences at Rice University has launched the Center for Nanoscale Imaging Sciences to improve the capture, analysis and interpretation of images at the nanometer scale. The center will push the frontiers of nanoscale imaging, contributing to breakthroughs in fields such as nanotechnology, materials science, biology and biomedicine.
Rice study unlocks breakthrough for breast cancer bone metastases
Rice University researchers in the lab of chemist Han Xiao have identified a promising new immunological pathway to treat stubborn bone tumors, one of most prevalent forms of metastases in breast cancer patients.
Fluorine catch-and-attach process could boost drug efficiency
Rice scientists have developed a new low-cost, safe and effective process to free up and reattach fluorine to chemical compounds. In pharmaceuticals, fluorine can expand lifetime, increase absorption and minimize side effects.
Rice expert available to comment on FDA decision on sickle cell disease therapy
Rice University’s Gang Bao is available to comment on today’s decision by the FDA on whether or not to approve a CRISPR-based therapy for sickle cell disease.
DREAM tool for gene therapies uses ‘locally sourced’ components
Rice bioengineers developed a tool that activates silent or insufficiently expressed genes using human-derived building blocks and a CRISPR-based genome-targeting platform.
Two Rice bioengineers win NIH Director’s New Innovator awards
Rice bioengineers Jerzy Szablowski and Julea Vlassakis received the NIH Director’s New Innovator Award for their respective research projects. Szablowski’s work seeks to develop a noninvasive method of mapping gene expression, while Vlassakis is studying complex, single-cell level processes and interactions in pediatric bone cancer.
